Why publish with Crohn’s & Colitis 360?

Crohn’s & Colitis 360 is a peer-reviewed, open access journal that publishes engaging and informative content that catalyzes dialogue on state-of-the-art comprehensive care for patients with inflammatory bowel disease (IBD) alongside the latest research to advance prevention, treatment, and cures. All articles in the journal publish under an open access license immediately upon publication so readers can gain full access to your work.

Crohn’s & Colitis 360 is an official journal of the Crohn's & Colitis Foundation and supports the Foundation’s mission by publishing research that will improve the quality of life of patients and bring us closer to cures.

Journal Impact Factor score

Crohn's & Colitis 360 has a Journal Impact Factor of 1.8 from Clarivate's Journal Citation Reports.

When you publish with Crohn's & Colitis 360, your research will contribute to the journal's future growth in impact and influence.

Indexed in PMC

Crohn's & Colitis 360 is now indexed in PubMed Central (PMC). All articles in the journal beginning with the first issue are now fully indexed, available, and searchable in the PMC repository.

PMC indexing supports the archiving and discoverability of your research article.

Open access options

Learn more about open access options, including whether you can publish open access for free as part of your institution’s inclusion in a read and publish agreement with Oxford University Press.

Rapid publication

Our associate editors make timely decisions on ‘review’ or ‘reject’, allowing authors to get feedback promptly. Average publication speeds for Crohn's & Colitis 360 are listed below:

Average time from submission to first decision: 31.5 days
Average reviewer turnaround time: 8 days

High quality peer review

The editors and associate editors have been selected for their global representation and expertise across a range of topics relevant to IBD. We have experts in translational science, epidemiology, outcomes research, as well as nutrition and psychology amongst our team of editors. This ensures your manuscript receives the appropriate level of consideration by thought leaders in these fields.

Global readership

Because Crohn's & Colitis 360 is a fully open access journal, it is accessible to readers from around the world. The journal includes readers in North America, Europe, and Asia.

Articles were read over 130,000 times in 2023.

Crohn's & Colitis 360 is engaged with the community

The journal features two fellow initiatives aimed at supporting Early Career Researchers:

The Fellow's Corner: a dedicated section of the journal containing training pearls from experienced faculty and original articles from fellows.
The Editorial Fellowship: a program for GI or IBD fellows to work alongside the journal's Associate Editors.

Learn more about the initiatives here.

Ready to publish your research?

Read our author guidelines for more information on publishing with us, including how to prepare your manuscript. Visit our online submissions site to submit your paper.